Authors
Loading...
Randomized trial identifies ferroptosis-related lncRNA signatures predicting outcomes in LSCC, suggesting a targeted role for immunotherapy.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: